六十株人源气单胞菌粪便分离株的抗菌药敏性

Antimicrobial susceptibility of sixty human fecal isolates of Aeromonas species.

作者信息

Kuijper E J, Peeters M F, Schoenmakers B S, Zanen H C

机构信息

Department of Medical Microbiology, University of Amsterdam, The Netherlands.

出版信息

Eur J Clin Microbiol Infect Dis. 1989 Mar;8(3):248-50. doi: 10.1007/BF01965270.

DOI:10.1007/BF01965270

PMID:2496995

Abstract

The MICs of 21 antimicrobial agents were determined for 60 strains of Aeromonas spp. isolated from human feces. All isolates tested were susceptible to aztreonam, tetracycline, imipenem, moxalactam, pipemidic acid, gentamicin, trimethoprim-sulfamethoxazole, pefloxacin and ciprofloxacin. Resistance to erythromycin and streptomycin was observed in all 60 strains. Aeromonas caviae was less susceptible to cefamandole, cefotaxime, norfloxacin, chloramphenicol, tetracycline, sulfamethoxazole and trimethoprim than was either Aeromonas hydrophila or Aeromonas sobria. It was concluded that cotrimoxazole or one of the newer quinolones can be considered for treatment of aeromonas-associated diarrhea.

摘要

测定了从人类粪便中分离出的60株气单胞菌属菌株对21种抗菌药物的最低抑菌浓度（MIC）。所有测试菌株对氨曲南、四环素、亚胺培南、拉氧头孢、吡哌酸、庆大霉素、甲氧苄啶-磺胺甲恶唑、培氟沙星和环丙沙星均敏感。在所有60株菌株中均观察到对红霉素和链霉素的耐药性。豚鼠气单胞菌比嗜水气单胞菌或温和气单胞菌对头孢孟多、头孢噻肟、诺氟沙星、氯霉素、四环素、磺胺甲恶唑和甲氧苄啶的敏感性更低。得出的结论是，复方新诺明或一种新型喹诺酮类药物可考虑用于治疗气单胞菌相关腹泻。